These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22109665)

  • 1. PET imaging of EGF receptors using [18F]FBEM-EGF in a head and neck squamous cell carcinoma model.
    Li W; Niu G; Lang L; Guo N; Ma Y; Kiesewetter DO; Backer JM; Shen B; Chen X
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):300-8. PubMed ID: 22109665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET of EGFR expression with an 18F-labeled affibody molecule.
    Miao Z; Ren G; Liu H; Qi S; Wu S; Cheng Z
    J Nucl Med; 2012 Jul; 53(7):1110-8. PubMed ID: 22689926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A thiol-reactive 18F-labeling agent, N-[2-(4-18F-fluorobenzamido)ethyl]maleimide, and synthesis of RGD peptide-based tracer for PET imaging of alpha v beta 3 integrin expression.
    Cai W; Zhang X; Wu Y; Chen X
    J Nucl Med; 2006 Jul; 47(7):1172-80. PubMed ID: 16818952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogue.
    Gao H; Niu G; Yang M; Quan Q; Ma Y; Murage EN; Ahn JM; Kiesewetter DO; Chen X
    Mol Pharm; 2011 Oct; 8(5):1775-82. PubMed ID: 21800885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two site-specifically (18)F-labeled affibodies for PET imaging of EGFR positive tumors.
    Su X; Cheng K; Jeon J; Shen B; Venturin GT; Hu X; Rao J; Chin FT; Wu H; Cheng Z
    Mol Pharm; 2014 Nov; 11(11):3947-56. PubMed ID: 24972326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging c-Met expression using 18F-labeled binding peptide in human cancer xenografts.
    Li W; Zheng H; Xu J; Cao S; Xu X; Xiao P
    PLoS One; 2018; 13(6):e0199024. PubMed ID: 29894497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-Specific Labeling of scVEGF with Fluorine-18 for Positron Emission Tomography Imaging.
    Wang H; Gao H; Guo N; Niu G; Ma Y; Kiesewetter DO; Chen X
    Theranostics; 2012; 2(6):607-17. PubMed ID: 22768028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma.
    Kiesewetter DO; Gao H; Ma Y; Niu G; Quan Q; Guo N; Chen X
    Eur J Nucl Med Mol Imaging; 2012 Mar; 39(3):463-73. PubMed ID: 22170321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of Epidermal Growth Factor Receptor Over-Expressing Tumors.
    Goux M; Becker G; Gorré H; Dammicco S; Desselle A; Egrise D; Leroi N; Lallemand F; Bahri MA; Doumont G; Plenevaux A; Cinier M; Luxen A
    Bioconjug Chem; 2017 Sep; 28(9):2361-2371. PubMed ID: 28825794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regiospecific radiolabelling of Nanofitin on Ni magnetic beads with [
    Dammicco S; Goux M; Lemaire C; Becker G; Bahri MA; Plenevaux A; Cinier M; Luxen A
    Nucl Med Biol; 2017 Aug; 51():33-39. PubMed ID: 28575696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary biological evaluation of ¹⁸F-FBEM-Cys-Annexin V a novel apoptosis imaging agent.
    Lu C; Jiang Q; Hu M; Tan C; Yu H; Hua Z
    Molecules; 2015 Mar; 20(3):4902-14. PubMed ID: 25789822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early response monitoring with 18F-FDG PET and cetuximab-F(ab')2-SPECT after radiotherapy of human head and neck squamous cell carcinomas in a mouse model.
    van Dijk LK; Boerman OC; Franssen GM; Lok J; Kaanders JH; Bussink J
    J Nucl Med; 2014 Oct; 55(10):1665-70. PubMed ID: 25236350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulinoma imaging with glucagon-like peptide-1 receptor targeting probe (18)F-FBEM-Cys (39)-exendin-4.
    Xu Y; Pan D; Xu Q; Zhu C; Wang L; Chen F; Yang R; Luo S; Yang M
    J Cancer Res Clin Oncol; 2014 Sep; 140(9):1479-88. PubMed ID: 24838847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 177Lu-DO3A-HSA-Z EGFR:1907: characterization as a potential radiopharmaceutical for radionuclide therapy of EGFR-expressing head and neck carcinomas.
    Hoppmann S; Qi S; Miao Z; Liu H; Jiang H; Cutler CS; Bao A; Cheng Z
    J Biol Inorg Chem; 2012 Jun; 17(5):709-18. PubMed ID: 22418921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
    Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M
    J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of epidermal growth factor receptor expression in head and neck cancer with SPECT/CT and 111In-labeled cetuximab-F(ab')2.
    van Dijk LK; Hoeben BA; Kaanders JH; Franssen GM; Boerman OC; Bussink J
    J Nucl Med; 2013 Dec; 54(12):2118-24. PubMed ID: 24136932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [18F]FBEM-Z(HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography.
    Kramer-Marek G; Kiesewetter DO; Martiniova L; Jagoda E; Lee SB; Capala J
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):1008-18. PubMed ID: 18157531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer.
    Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC
    J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Zettlitz KA; Tavaré R; Tsai WK; Yamada RE; Ha NS; Collins J; van Dam RM; Timmerman JM; Wu AM
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):489-500. PubMed ID: 30456475
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.